Precision caffeine therapy for apnea of prematurity and circadian rhythms: New possibilities open up

Caffeine is the globally consumed psychoactive substance and the drug of choice for the treatment of apnea of prematurity (AOP), but its therapeutic effects are highly variable among preterm infants. Many of the molecular underpinnings of the marked individual response have remained elusive yet. Int...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Hao-Ran, Guo, Hong-Li, Hu, Ya-Hui, Xu, Jing, Ding, Xuan-Sheng, Cheng, Rui, Chen, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753576/
https://www.ncbi.nlm.nih.gov/pubmed/36532766
http://dx.doi.org/10.3389/fphar.2022.1053210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753576/
https://www.ncbi.nlm.nih.gov/pubmed/36532766
http://dx.doi.org/10.3389/fphar.2022.1053210

Ejemplares similares